Bioorganic and Medicinal Chemistry Letters p. 1231 - 1236 (1998)
Update date:2022-08-03
Topics:
Gleave, D. Mark
Brickner, Steven J.
Manninen, Peter R.
Allwine, Debra A.
Lovasz, Kristine D.
Rohrer, Douglas C.
Tucker, John A.
Zurenko, Gary E.
Ford, Charles W.
A series of conformationally restricted, [6,5,5] and [6,6,5] tricyclic fused oxazolidinones were synthesized and tested for antibacterial activity. Several compounds in the trans-[6,5,5] series demonstrated potent in vitro and in vivo activity. This work provides valuable information regarding the preferred conformational orientation of the oxazolidinones at the binding site.
View MoreTAIZHOU XINGCHENG CHEMPHARM CO.,LTD.
Contact:0086-0576-88551200,88886292 ,88880039
Address:B Area. 10 Floor.Yaodadasha. 289#.Shifu Road.Taizhou.Zhejiang.China
Shanghai Yingrui Biopharma Co., Ltd
Contact:021-3358 8661*8003
Address:shanghai
HANGZHOU EVC CHEMICAL CO.,LTD.(expird)
Contact:+86-571-88296056
Address:Room#3001,Zhejiang Chemical Market,No.10,Road Shenban,Hangzhou,Zhejiang,China
Jiaozuo Zhongwei Special Products Pharmaceutical Co.,Ltd.
website:http://www.zw-pvp.com
Contact:15302105619
Address:Jiaozuo,Henan,China (Mainland)
Doi:10.1016/S0040-4039(02)00857-2
(2002)Doi:10.1021/om980035w
(1998)Doi:10.1016/j.bmcl.2004.02.071
(2004)Doi:10.1021/acs.orglett.5b00295
(2015)Doi:10.1016/S0022-328X(97)00720-1
(1998)Doi:10.1021/jo980367a
(1998)
